Established in 2017, MEGALITH PHARMACEUTICALS, INC. (Megalith) is a pharmaceutical distributor headquartered in Princeton, New Jersey. CSPC Pharmaceutical Group Limited (“CSPC”) provide the ANDA products for Megalith.

CSPC is a leading pharmaceutical group in China with the broad manufacturing capabilities to bring multiple dosage forms to customers in the U.S., Europe, and China. The turnover is over $4B in 2017. This unique strength, combined with the powerful R&D engine, sets the foundation today for an even greater offering of medicines in the future. Along with manufacturing and marketing a variety of finished dosage forms, CSPC has been supplying active pharmaceutical ingredients (API) to major brand and generic pharmaceutical manufacturers in the US and around the world for years. The company has been listed on the Hong Kong Stock Exchange since 1994. Now, Megalith is proud to introduce their products in the United States.

MEGALITH launched ANDA products Clopidogrel Bisulphate tablets (compare to PlavixⓇ) and Metformin HCl tablets (compare to GlucophageⓇ) and Gabapentin tablets (compare to NeurotinⓇ) into the U.S. market in 2018. More good products are coming soon.